Dr. Anthony V Greco, M.D., F.A.A.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 108 Pleasant St, Mount Pleasant, TX 75455 Phone: 903-577-8878 Fax: 903-577-8936 |
News Archive
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved NESINA (alogliptin) and the fixed-dose combination (FDC) therapies OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl) for the treatment of type 2 diabetes in adults as adjuncts to diet and exercise.
To address the current reactive approaches to treating chronic and post-acute care conditions, SAP AG is launching a new solution. The SAPĀ® Collaborative E-Care Management application connects patients, care providers and their families through medical monitoring software and mobile devices to better manage their health with individualized treatment plans and educational content.
Roll Call reports that the two longtime Connecticut Senators, Democrat Chris Dodd and Independent Joe Lieberman, are at "near-opposite ends of a health care debate that amounts to Congress' biggest undertaking in a generation." The relationship between to the two lawmakers was strained in 2008, when Dodd ran for president, but Lieberman supported Republican John McCain. In 2006, Lieberman left the Democratic Party after losing a primary race and Dodd endorsed his challenger.
The Terason t3000 CV Ultrasound is the ultrasound system of choice for The HEARTS Program a project of Memorial Hermann and UT Southwestern Hospitals. Houston Early Age Risk Testing and Screening (HEARTS) program, is a study designed to detect any abnormal heart conditions that can cause the heart to arrest.
› Verified 2 days ago